For decades, a diagnosis of glioblastoma – an aggressive, hard-to-treat cancer in the brain – has been a death sentence for patients.



7089020

KRDO

Colorado Springs

El Paso County

Colorado

United States

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least […]

Ad Fontes Media

All Sides

Media Bias/Fact Check

Associated Press News

Independent Media

A new strategy to attack aggressive brain cancer shrank tumors in two early tests - Seymour Tribune

Researchers revved up immune cells that shrank an extremely aggressive type of brain tumor when tested in a handful of patients

abc News

The Walt Disney Company

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

Three studies published within the past week have reported dramatic results with a therapy called CAR-T delivered directly to the brain. In some cases, tumors have seemingly melted away on brain scans by the next day.

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

By Brenda Goodman, CNN (CNN) — For decades, a diagnosis of glioblastoma – an aggressive, hard-to-treat cancer in the brain – has been a death sentence for patients. Only 3% to 5% of people who are diagnosed with this type of brain tumor will be alive three years later. On average, patients live about 14 months after diagnosis. Now, an experimental therapy that reprograms a person’s own immune cells to attack these tumors is showing some exciting…

News-Press & Gazette Company

The Washington Post

Jeff Bezos

By LAURAN NEERGAARD
AP Medical Writer WASHINGTON (AP) — Researchers revved up immune cells that shrank an extremely aggressive type of brain tumor when tested in a handful of patients. The experiments are just first steps but they signal a new strategy to fight hard-to-treat glioblastoma. It’s a twist on the CAR-T therapy already used to treat leukemia, by modifying patients’ own disease-fighting T cells to be better cancer hunters. Now Massachu…

KVIA

Panama City

Bay County

Florida

WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ […]

Winnipeg Free Press

Winnipeg

Manitoba

Canada

A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but…

WPLG

Howard Buffett

Miami

Miami-Dade County

WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday. So-called CAR-T therapy already is used to fight blood-related cance…

My Mother Lode

A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics